Lake Street Maintains Buy on Evogene, Raises Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Ben Klieve maintains a 'Buy' rating on Evogene (NASDAQ:EVGN) and raises the price target from $2 to $3.
August 18, 2023 | 3:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lake Street analyst maintains a 'Buy' rating on Evogene and raises the price target from $2 to $3.
The raised price target by Lake Street analyst indicates a positive outlook for Evogene. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100